Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia

David Hasdai, Verghese Mathew, Robert S. Schwartz, Leslie A. Smith, David Holmes, Zvonimir S Katusic, Amir Lerman

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The coronary vasoconstrictor effects of endothelins, mediated by both endothelin ETA and ETB receptors, may be differentially altered in pathophysiological states associated with endothelial dysfunction and elevated endothelin levels. Experimental hypercholesterolemia is associated with coronary endothelial dysfunction and increased circulating endothelin concentrations. These studies were designed to test the hypothesis that experimental hypercholesterolemia is characterized by a differentially altered coronary contractile response to ETA- and ETB-receptor stimulation, in vitro. Pigs were fed either a normal or a high-cholesterol diet for 10 to 13 weeks. Changes in the intraluminal diameter of pressurized small coronary arteries (<481±25 μm in diameter) to cumulative concentrations (10-10 to 10-6 mol/L) of endothelin-1 (ET-1), and sarafotoxin 6c (S6c), a specific ETB-receptor agonist, were measured using a video dimension analyzer. The maximal contraction attained with ET-1 was greater than with S6c in both normal (86±7% versus 47±7%, P=.001) and hypercholesterolemic (77±6% versus 37±7%, P<.001) pigs. At 10-10 mol/L, vessels from hypercholesterolemic pigs manifested greater contraction to both ET-1 (23±6% versus 8±3%, P=.02) and S6c (17±5% versus 4±2%, P=.02). Incubation of arteries from hypercholesterolemic pigs with BQ-788 (ETB-receptor antagonist), but not FR- 139317 (ETA-receptor antagonist), altered the contractile response to ET-1 at 10-10 mol/L. Removal of the endothelium abolished the difference in response to S6c between normal and hypercholesterolemic pigs. These studies demonstrate that experimental hypercholesterolemia is characterized by enhanced coronary vasoconstriction to endothelins in vitro, the mechanism of which is mediated mainly through the ETB receptor. Thus, the ETB receptor has a role in regulation of coronary artery tone in both the steady-state and pathophysiological states.

Original languageEnglish (US)
Pages (from-to)2737-2743
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume17
Issue number11
StatePublished - 1997

Fingerprint

Endothelin B Receptors
Endothelins
Hypercholesterolemia
Vasoconstriction
Endothelin-1
Coronary Vessels
Swine
Diet
Vasoconstrictor Agents
Endothelium
Arteries
Cholesterol
sarafotoxins s6

Keywords

  • Endothelin
  • Endothelium
  • Hypercholesterolemia
  • Pigs
  • Receptors
  • Sarafotoxin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia. / Hasdai, David; Mathew, Verghese; Schwartz, Robert S.; Smith, Leslie A.; Holmes, David; Katusic, Zvonimir S; Lerman, Amir.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 17, No. 11, 1997, p. 2737-2743.

Research output: Contribution to journalArticle

@article{a0c0b03fd74a471e907cc24d42f81fb3,
title = "Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia",
abstract = "The coronary vasoconstrictor effects of endothelins, mediated by both endothelin ETA and ETB receptors, may be differentially altered in pathophysiological states associated with endothelial dysfunction and elevated endothelin levels. Experimental hypercholesterolemia is associated with coronary endothelial dysfunction and increased circulating endothelin concentrations. These studies were designed to test the hypothesis that experimental hypercholesterolemia is characterized by a differentially altered coronary contractile response to ETA- and ETB-receptor stimulation, in vitro. Pigs were fed either a normal or a high-cholesterol diet for 10 to 13 weeks. Changes in the intraluminal diameter of pressurized small coronary arteries (<481±25 μm in diameter) to cumulative concentrations (10-10 to 10-6 mol/L) of endothelin-1 (ET-1), and sarafotoxin 6c (S6c), a specific ETB-receptor agonist, were measured using a video dimension analyzer. The maximal contraction attained with ET-1 was greater than with S6c in both normal (86±7{\%} versus 47±7{\%}, P=.001) and hypercholesterolemic (77±6{\%} versus 37±7{\%}, P<.001) pigs. At 10-10 mol/L, vessels from hypercholesterolemic pigs manifested greater contraction to both ET-1 (23±6{\%} versus 8±3{\%}, P=.02) and S6c (17±5{\%} versus 4±2{\%}, P=.02). Incubation of arteries from hypercholesterolemic pigs with BQ-788 (ETB-receptor antagonist), but not FR- 139317 (ETA-receptor antagonist), altered the contractile response to ET-1 at 10-10 mol/L. Removal of the endothelium abolished the difference in response to S6c between normal and hypercholesterolemic pigs. These studies demonstrate that experimental hypercholesterolemia is characterized by enhanced coronary vasoconstriction to endothelins in vitro, the mechanism of which is mediated mainly through the ETB receptor. Thus, the ETB receptor has a role in regulation of coronary artery tone in both the steady-state and pathophysiological states.",
keywords = "Endothelin, Endothelium, Hypercholesterolemia, Pigs, Receptors, Sarafotoxin",
author = "David Hasdai and Verghese Mathew and Schwartz, {Robert S.} and Smith, {Leslie A.} and David Holmes and Katusic, {Zvonimir S} and Amir Lerman",
year = "1997",
language = "English (US)",
volume = "17",
pages = "2737--2743",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia

AU - Hasdai, David

AU - Mathew, Verghese

AU - Schwartz, Robert S.

AU - Smith, Leslie A.

AU - Holmes, David

AU - Katusic, Zvonimir S

AU - Lerman, Amir

PY - 1997

Y1 - 1997

N2 - The coronary vasoconstrictor effects of endothelins, mediated by both endothelin ETA and ETB receptors, may be differentially altered in pathophysiological states associated with endothelial dysfunction and elevated endothelin levels. Experimental hypercholesterolemia is associated with coronary endothelial dysfunction and increased circulating endothelin concentrations. These studies were designed to test the hypothesis that experimental hypercholesterolemia is characterized by a differentially altered coronary contractile response to ETA- and ETB-receptor stimulation, in vitro. Pigs were fed either a normal or a high-cholesterol diet for 10 to 13 weeks. Changes in the intraluminal diameter of pressurized small coronary arteries (<481±25 μm in diameter) to cumulative concentrations (10-10 to 10-6 mol/L) of endothelin-1 (ET-1), and sarafotoxin 6c (S6c), a specific ETB-receptor agonist, were measured using a video dimension analyzer. The maximal contraction attained with ET-1 was greater than with S6c in both normal (86±7% versus 47±7%, P=.001) and hypercholesterolemic (77±6% versus 37±7%, P<.001) pigs. At 10-10 mol/L, vessels from hypercholesterolemic pigs manifested greater contraction to both ET-1 (23±6% versus 8±3%, P=.02) and S6c (17±5% versus 4±2%, P=.02). Incubation of arteries from hypercholesterolemic pigs with BQ-788 (ETB-receptor antagonist), but not FR- 139317 (ETA-receptor antagonist), altered the contractile response to ET-1 at 10-10 mol/L. Removal of the endothelium abolished the difference in response to S6c between normal and hypercholesterolemic pigs. These studies demonstrate that experimental hypercholesterolemia is characterized by enhanced coronary vasoconstriction to endothelins in vitro, the mechanism of which is mediated mainly through the ETB receptor. Thus, the ETB receptor has a role in regulation of coronary artery tone in both the steady-state and pathophysiological states.

AB - The coronary vasoconstrictor effects of endothelins, mediated by both endothelin ETA and ETB receptors, may be differentially altered in pathophysiological states associated with endothelial dysfunction and elevated endothelin levels. Experimental hypercholesterolemia is associated with coronary endothelial dysfunction and increased circulating endothelin concentrations. These studies were designed to test the hypothesis that experimental hypercholesterolemia is characterized by a differentially altered coronary contractile response to ETA- and ETB-receptor stimulation, in vitro. Pigs were fed either a normal or a high-cholesterol diet for 10 to 13 weeks. Changes in the intraluminal diameter of pressurized small coronary arteries (<481±25 μm in diameter) to cumulative concentrations (10-10 to 10-6 mol/L) of endothelin-1 (ET-1), and sarafotoxin 6c (S6c), a specific ETB-receptor agonist, were measured using a video dimension analyzer. The maximal contraction attained with ET-1 was greater than with S6c in both normal (86±7% versus 47±7%, P=.001) and hypercholesterolemic (77±6% versus 37±7%, P<.001) pigs. At 10-10 mol/L, vessels from hypercholesterolemic pigs manifested greater contraction to both ET-1 (23±6% versus 8±3%, P=.02) and S6c (17±5% versus 4±2%, P=.02). Incubation of arteries from hypercholesterolemic pigs with BQ-788 (ETB-receptor antagonist), but not FR- 139317 (ETA-receptor antagonist), altered the contractile response to ET-1 at 10-10 mol/L. Removal of the endothelium abolished the difference in response to S6c between normal and hypercholesterolemic pigs. These studies demonstrate that experimental hypercholesterolemia is characterized by enhanced coronary vasoconstriction to endothelins in vitro, the mechanism of which is mediated mainly through the ETB receptor. Thus, the ETB receptor has a role in regulation of coronary artery tone in both the steady-state and pathophysiological states.

KW - Endothelin

KW - Endothelium

KW - Hypercholesterolemia

KW - Pigs

KW - Receptors

KW - Sarafotoxin

UR - http://www.scopus.com/inward/record.url?scp=0031439532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031439532&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 2737

EP - 2743

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 11

ER -